RT Journal Article
SR Electronic
T1 Radiology reporting of adrenal incidentalomas – who requires further testing?
JF Clinical Medicine
JO Clin Med
FD Royal College of Physicians
SP 16
OP 21
DO 10.7861/clinmedicine.14-1-16
VO 14
IS 1
A1 Fiona Paterson
A1 Aikaterini Theodoraki
A1 Adaugo Amajuoyi
A1 Pierre-Marc Bouloux
A1 Jody Maclachlan
A1 Bernard Khoo
YR 2014
UL http://www.rcpjournals.org/content/14/1/16.abstract
AB Adrenal incidentalomas (AIs) are common and guidelines recommend testing to exclude functioning lesions and malignancy. Their increasing prevalence results in several investigations that are usually conducted in the endocrinology clinic. In 2011, we audited the prevalence and management of AIs identified on computed tomography (CT) imaging of abdomen over 1 calendar month. Consequently, a decision pathway for adrenal lesions was introduced in the radiology department of the Royal Free London Hospital. One year later, we re-audited the local practice. In total, 690 CT scans were reviewed in 2011 compared with 1,264 in 2012. In 2011, 17 (2.46%) patients with AIs were identified, and 26 (2.01%) in 2012. Of those, 1.01% in 2011 and 0.95% in 2012 had newly identified AIs. Only a few patients had been tested to exclude a functional lesion and there was inconsistent terminology in reporting adrenal lesions. Therefore, we support comprehensive reporting of AIs and a selective testing strategy.